It all started more than 10 years ago with three people in a room in Cardiff, talking about ways to improve outcomes in the world’s most common type of cancer – oestrogen receptor positive breast cancer. This led to the FAKTION clinical trial, investigating whether we could safely combine standard hormone therapy with AstraZeneca’s AKT inhibitor capivasertib, and did the combination improve patient outcomes.
A research trial opened recently marks the first commercial medical device trial lead by the Radiotherapy Research team at Velindre Cancer Centre. The SABRE trial involves the use of the SpaceOAR Vue system designed by Boston Scientific in patients being treated with radiotherapy for prostate cancer.
Open Welsh Blood Service's May 2023 Research, Development and Innovation report to read more about Felicity May's research project.
A major UK clinical trial to treat the most aggressive brain tumour has opened at the Velindre Cancer Centre. The three-year Phase II trial ARISTOCRAT is funded by The Brain Tumour Charity and will investigate whether combining cannabinoids and chemotherapy can help extend the lives of people diagnosed with recurrent glioblastoma.
Towards the end of 2023 research scientist Michael Cahillane was selected to take part in the Bevan Commission’s Innovation Intensive Learning Week focusing on his project looking at reducing waste in the process of manufacturing pooled cryoprecipitate.
More than 150 patients contributed to important study into blood clots in palliative care patients with cancer. The study which closed at the end of September 2023 is called HIDDEN2: Hospital deep vein thrombosis detection study in cancer patients receiving palliative care, and looked at patients who were admitted acutely to hospital.
The Cardiff Cancer Research Hub is a dynamic working partnership between Velindre University NHS Trust, Cardiff and Vale University Health Board and Cardiff University.
The first patient has joined the first clinical trial with the Hub - Find out more about Agustina’s experience of starting a new clinical trial with this short video.
Number of studies in our portfolio
Study performance rankings 2023-24
Number of participants recruited to studies 2021 - 24